Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evidence of chromaffin oxygen sensing in neuroblastoma.
Hedborg F, Franklin G, Norrman J, Grimelius L, Wassberg E, Hero B, Schilling F, Berthold F, Harms D, Sandstedt B. Hedborg F, et al. Among authors: schilling f. Med Pediatr Oncol. 2001 Jan;36(1):149-53. doi: 10.1002/1096-911X(20010101)36:1<149::AID-MPO1036>3.0.CO;2-M. Med Pediatr Oncol. 2001. PMID: 11464871
Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R, Ambros IM, Pötschger U, Amann G, Urban C, Fink FM, Schmitt K, Jones R, Slociak M, Schilling F, Ritter J, Berthold F, Gadner H, Ambros PF. Ladenstein R, et al. Among authors: schilling f. Med Pediatr Oncol. 2001 Jan;36(1):83-92. doi: 10.1002/1096-911X(20010101)36:1<83::AID-MPO1020>3.0.CO;2-9. Med Pediatr Oncol. 2001. PMID: 11464912
Somatostatin in neuroblastoma and ganglioneuroma.
Kogner P, Borgström P, Bjellerup P, Schilling FH, Refai E, Jonsson C, Dominici C, Wassberg E, Bihl H, Jacobsson H, Theodorsson E, Hassan M. Kogner P, et al. Among authors: schilling fh. Eur J Cancer. 1997 Oct;33(12):2084-9. doi: 10.1016/s0959-8049(97)00212-8. Eur J Cancer. 1997. PMID: 9516858
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group.
Favrot MC, Ambros P, Schilling F, Frappaz D, Combaret V, Berthold F, Dominici C, Erttmann R, Esteve J, Jenkner A, Kerbl R, Mann J, Mathieu P, Parker L, Powell J, Philip T. Favrot MC, et al. Among authors: schilling f. Ann Oncol. 1996 Aug;7(6):607-11. doi: 10.1093/oxfordjournals.annonc.a010678. Ann Oncol. 1996. PMID: 8879375 Free article. Review.
Heterogeneity of the MYCN oncogene in neuroblastoma.
Theissen J, Boensch M, Spitz R, Betts D, Stegmaier S, Christiansen H, Niggli F, Schilling F, Schwab M, Simon T, Westermann F, Berthold F, Hero B. Theissen J, et al. Among authors: schilling f. Clin Cancer Res. 2009 Mar 15;15(6):2085-90. doi: 10.1158/1078-0432.CCR-08-1648. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276282
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.
Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, Klingebiel T, Kremens B, Schilling FH, Schrappe M, Simon T, Hero B. Berthold F, et al. Among authors: schilling fh. Lancet Oncol. 2005 Sep;6(9):649-58. doi: 10.1016/S1470-2045(05)70291-6. Lancet Oncol. 2005. PMID: 16129365 Clinical Trial.
347 results